Non-small cell lung cancer (NSCLC) with higher blood tumor mutational burden (bTMB)/tissueTMB (tTMB) ratio is associated with inferior survival outcome

被引：0
|
作者：
Kim, Leeseul
Park, Jewel
Oh, Youjin
Chae, Young Kwang
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3376
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer
    Zhou, J.
    Zhou, J.
    Chen, X.
    Zhu, Y.
    Fang, L.
    Bao, Z.
    Liu, R.
    Cao, H.
    Sun, W.
    Zhang, T.
    Lin, J.
    Yu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S370 - S370
  • [2] Blood tumor mutational burden (bTMB) from circulating tumor DNA (ctDNA) as a biomarker for both mutational status and tumor burden in non-small cell lung cancer (NSCLC)
    Davis, Andrew A.
    Galvez, Carlos
    Pan, Alan
    Mohindra, Nisha
    Villaflor, Victoria
    Chae, Young Kwang
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Cai, Jingjing
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Li, Hongsheng
    Ma, Luyao
    Huang, Yunchao
    Zhou, Yongchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [5] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
  • [6] Comparison of platforms for determining tumor mutational burden (TMB) from blood samples in patients with non-small cell lung cancer (NSCLC)
    Baden, J.
    Chang, H.
    Greenawalt, D. M.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Srinivasan, S.
    Green, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
  • [7] Harmonization study of tumour mutational burden determination in non-small cell lung cancer (NSCLC)
    Garrido-Martin, E. M.
    Ramos-Paradas, J.
    Prieto, S. Hernandez
    Sanchez, E.
    Rosado, A.
    Caniego-Casas, T.
    Carrizo, N.
    Enguita, A. B.
    Munoz-Jimenez, M. T.
    Rodriguez, B.
    Perez-Gonzalez, U.
    Gomez Sanchez, D.
    Ferrer, I.
    Ponce Aix, S.
    Nunez Buiza, A.
    Garrido, P.
    Palacios, J.
    Lopez-Rios, F.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 852 - 852
  • [8] Impact of tumor mutational burden on overall survival in patients with non-small cell lung cancer treated with immunotherapy
    Awad, Mark
    Mahadevan, Navin
    Polio, Andrew
    Vokes, Natalie
    Aguilar, Elizabeth
    Ricciuti, Biagio
    Lamberti, Giuseppe
    Recondo, Gonzalo
    Leonardi, Giulia
    Adeni, Anika
    Janne, Pasi
    Van Allen, Eliezer
    Albayrak, Adem
    Umeton, Renato
    Sholl, Lynette
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Changes in tumor mutational burden in serially biopsied non-small cell lung cancer
    Smithy, James
    Smithy, James
    Hwang, David
    Li, Yvonne
    Spurr, Liam
    Cherniack, Andrew
    Sholl, Lynette
    Awad, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
    van den Heuvel, Guus R. M.
    Kroeze, Leonie I.
    Ligtenberg, Marjolijn J. L.
    Grunberg, Katrien
    Jansen, Erik A. M.
    von Rhein, Daniel
    de Voer, Richarda M.
    van den Heuvel, Michel M.
    RESPIRATORY RESEARCH, 2021, 22 (01)
12345